NCT06457204 - A Study in Healthy People to Compare Two Different Sifrol® Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions

Healthy

Interventions

DRUG

Pramipexole manufactured in Ingelheim

1 tablet Sifrol® (pramipexole) manufactured in Ingelheim containing 0.088 mg pramipexole taken orally after an overnight fast of at least 10 hours.

DRUG

Pramipexole manufactured in Ennigerloh

1 tablet Sifrol® (pramipexole) manufactured in Ennigerloh containing 0.088 mg pramipexole taken orally after an overnight fast of at least 10 hours.

Trial Locations (1)

Humanpharmakologisches Zentrum Biberach, Biberach